These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 37371090)
41. Ezrin expression in circulating tumor cells is a predictor of prostate cancer metastasis. Chen Z; Wang J; Lu Y; Lai C; Qu L; Zhuo Y Bioengineered; 2022 Feb; 13(2):4076-4084. PubMed ID: 35156523 [TBL] [Abstract][Full Text] [Related]
42. Role of Ezrin in Asthma-Related Airway Inflammation and Remodeling. Zhao S; Luo J; Hu J; Wang H; Zhao N; Cao M; Zhang C; Hu R; Liu L Mediators Inflamm; 2022; 2022():6255012. PubMed ID: 36530558 [TBL] [Abstract][Full Text] [Related]
43. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells. Mak H; Naba A; Varma S; Schick C; Day A; SenGupta SK; Arpin M; Elliott BE BMC Cancer; 2012 Mar; 12():82. PubMed ID: 22397367 [TBL] [Abstract][Full Text] [Related]
44. Role for ezrin in breast cancer cell chemotaxis to CCL5. Li J; Tu Y; Wen J; Yao F; Wei W; Sun S Oncol Rep; 2010 Oct; 24(4):965-71. PubMed ID: 20811677 [TBL] [Abstract][Full Text] [Related]
45. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells. Kocher HM; Sandle J; Mirza TA; Li NF; Hart IR Gut; 2009 Feb; 58(2):271-84. PubMed ID: 18852256 [TBL] [Abstract][Full Text] [Related]
46. Gem associates with Ezrin and acts via the Rho-GAP protein Gmip to down-regulate the Rho pathway. Hatzoglou A; Ader I; Splingard A; Flanders J; Saade E; Leroy I; Traver S; Aresta S; de Gunzburg J Mol Biol Cell; 2007 Apr; 18(4):1242-52. PubMed ID: 17267693 [TBL] [Abstract][Full Text] [Related]
47. Ezrin and moesin expression in canine and feline osteosarcoma. Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754 [TBL] [Abstract][Full Text] [Related]
48. Role of ezrin in osteosarcoma metastasis. Ren L; Khanna C Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175 [TBL] [Abstract][Full Text] [Related]
49. Knockdown of Ezrin inhibited migration and invasion of cervical cancer cells in vitro. Xi M; Tang W Int J Immunopathol Pharmacol; 2020; 34():2058738420930899. PubMed ID: 32674647 [TBL] [Abstract][Full Text] [Related]
50. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products. McRobert EA; Bach LA Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400 [TBL] [Abstract][Full Text] [Related]
51. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer. Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714 [TBL] [Abstract][Full Text] [Related]
52. Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro. Zhong ZQ; Song MM; He Y; Cheng S; Yuan HS Asian Pac J Cancer Prev; 2012; 13(8):3781-9. PubMed ID: 23098471 [TBL] [Abstract][Full Text] [Related]
53. The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype. Brambilla D; Fais S Int J Cancer; 2009 Nov; 125(10):2239-45. PubMed ID: 19588507 [TBL] [Abstract][Full Text] [Related]
54. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. Ou-Yang M; Liu HR; Zhang Y; Zhu X; Yang Q Biochimie; 2011 May; 93(5):954-61. PubMed ID: 21352885 [TBL] [Abstract][Full Text] [Related]
55. Properties of an ezrin mutant defective in F-actin binding. Saleh HS; Merkel U; Geissler KJ; Sperka T; Sechi A; Breithaupt C; Morrison H J Mol Biol; 2009 Jan; 385(4):1015-31. PubMed ID: 19084535 [TBL] [Abstract][Full Text] [Related]
57. [Expression and significance of Ezrin gene in pancreatic carcinoma tissues]. Duan L; Li YX; Hu GH; Tang HH; Tao YM Ai Zheng; 2008 Dec; 27(12):1337-40. PubMed ID: 19080005 [TBL] [Abstract][Full Text] [Related]
58. Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma. Xie YH; Li LY; He JZ; Xu XE; Liao LD; Zhang Q; Xie JJ; Xu LY; Li EM Int J Biochem Cell Biol; 2019 Jul; 112():79-87. PubMed ID: 31082616 [TBL] [Abstract][Full Text] [Related]
59. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis]. Li J; Liang SH; Lu X Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563 [TBL] [Abstract][Full Text] [Related]
60. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma. Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]